rise in the prevalence of Helicobacter pylori infection, higher demand for early recognition of symptoms, and advancements in diagnostic methods all contribute to the market's growth.
According to forecasts, the global market for treating Helicobacter pylori infections is expected to reach a value of US$ 638.3 million by 2023, and is projected to have a compound annual growth rate (CAGR) of 7.04% from 2023 to 2033, resulting in a total value of US$ 1,260 million. Factors such as inadequate water supply, poor sanitation, large population, and insufficient personal hygiene are contributing to the spread of this infection. Increased awareness of H. pylori infections is one of the driving factors for the growth of the Helicobacter pylori diagnostics market.
The use of antibiotics is expected to increase due to the availability and affordability of antibiotics, as well as faster processing times, leading to a higher demand for pre and post-surveillance tests. Additionally, the need for early symptom detection, technological advancements in diagnostic techniques, and the rising rate of H. pylori infections are expected to drive overall growth in the forecast period.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16291
The main drivers of the industry are the increasing prevalence of communicable diseases and greater public awareness of infections such as tuberculosis, Chlamydia, gonorrhea, other sexually transmitted diseases (STDs), stomach flu (gastroenteritis), and urinary tract infections (UTIs). During the forecast period, North America is expected to dominate the global Helicobacter pylori diagnostics market due to factors such as an increase in disease transmission, greater awareness of communicable diseases, and the launch of new products.
Key Takeaways from Market Study
“With a rise in the prevalence of chronic diseases, demand for helicobacter pylori treatment is rising, paving way for new approaches to treatment and therapeutics,” remarks an analyst at FMI.
Ask Our Analyst More About Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-16291
Market Competition
Key players in the Helicobacter Pylori Infections Market are:
Want More Insights:
North America is the largest helicobacter pylori infections market due to the high prevalence of the infection in the region. The United States dominates the market in North America, with a large patient population and well-established healthcare infrastructure. The country has also approved several drugs for the treatment of H. pylori infections, such as clarithromycin, amoxicillin, and metronidazole.
Buy Complete Report@ https://www.futuremarketinsights.com/checkout/16291
Key Segments Profiled in the Helicobacter Pylori Infections Treatment Market Industry Survey
By Treatment:
By Application:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.
Jun 09, 2023